What’s causing the infant-formula probe in Europe?

Investigations and legal fallout in the formula sector

European authorities and affected families have focused scrutiny on a recent cluster of formula-related safety failures. Prosecutors in Paris have opened inquiries that name several major manufacturers; the probe centers on contamination with a toxin linked to a series of product recalls and illnesses.

The situation has unfolded on multiple fronts:

• Judicial investigations: France’s prosecutor has begun formal inquiries into producers implicated by the contamination, signaling potential criminal or administrative consequences if lapses are found in manufacturing or oversight.
• Corporate exposure: Several large infant-formula brands are under examination; regulators are reviewing manufacturing records, distribution chains and safety testing regimes.
• Legal action by families: More than 20 families in France have initiated lawsuits, arguing that authorities and companies failed to prevent or properly manage the contamination and its consequences.

Beyond Europe, regulators elsewhere have also moved. For example, Brazil issued a recall over elevated iodine and selenium levels in a specialty formula, drawing attention to the global reach of formula-safety concerns.

Why this matters: infant nutrition is a uniquely sensitive product category, because the consumers are young and vulnerable. Recalls and probes erode public confidence, prompt regulatory tightening, and can force wide product withdrawals that disrupt supply. Where investigations find systemic failures, companies can face fines, mandated changes to production, and long legal processes.

What remains uncertain is the full scope of the contamination and how quickly families, health officials and manufacturers will see the supply chain stabilized. Regulators say they will continue reviewing evidence and, when necessary, pursue legal remedies and tighter controls to prevent recurrence.